he's not on TRT, however. he doesn't have the overall hormonal suppression that occurs from that. a lot of people forget the role that the testes play in aromatization, and that their shutdown on an AAS cycle reduces issues with that. and since his HPTA is not suppressed, there is also the aromatization that occurs from androstendione, something else that ceases on TRT/AAS use...
in this instance, i think looking at the clinical data of the use of an AI is pretty clear cut...
like i said before, there's plenty of data out there:
and while Ralox/Nolva might not remove the gyno completely, there's also plenty of clinical and anecdotal evidence that they can shrink the size of it substantially.
^i'll reiterate, to clarify my points.
in this case, Aromasin seems to the best best choice, for several reasons. while it's a little weaker than letro and a-dex, it is less likely to drop the estrogen levels too low. also, it's faster acting, and the shorter half-life allows it to be adjusted easier. and since it is a suicidal AI, the risk of estrogen rebound appears to be smaller, as well.
and ralox is slightly more effective than nolva at treating gyno. additionally, it is less likely to raise testosterone levels as much as nolva, which is unnecessary at this point, as we don't want test to be so high it encourages additional aromatization.